Table 1. Summary of serum oxylipins in women with endometriosis (EM+) and without (EM−).

Analyte	EM− Average conc. (nM)	EM + Average conc. (nM)	EM− vs EM+ (p-value)	EM− vs EM+Mild (p-value)	EM− vs EM+Sev (p-value)	EM− vs EM+ovar (p-value)	EM− vs EM+perit (p-value)
5,6-DHET	0.075	0.079	0.82	0.16	0.47	0.66	0.33
8,9-DHET	0.006	0.006	0.82	0.53	0.55	0.73	0.94
11,12-DHET	0.053	0.050	0.60	0.06	0.81	0.81	0.19
14,15-DHET	0.063	0.061	0.76	0.13	0.70	0.97	0.14
12,13-DIHOME	0.693	0.632	0.58	0.67	0.65	0.44	0.86
9,10-DIHOME	0.559	0.412	0.22	0.40	0.30	0.17	0.78
5-HETE	0.061	0.060	0.91	0.95	0.85	0.83	0.77
8-HETE	0.016	0.018	0.65	0.42	0.93	0.71	0.32
11-HETE	0.227	0.201	0.66	1.00	0.54	0.66	0.91
12-HETE	0.219	0.108	0.06	0.19	0.13	0.03	0.49
13-HODE	3.041	3.211	0.74	0.90	0.59	0.45	0.86
15-HETE	0.066	0.065	0.95	0.74	0.73	0.95	0.68
20-HETE	0.004	0.004	0.47	0.08	0.94	0.91	0.20
5-HEPE	0.016	0.016	0.90	0.58	0.67	0.61	0.50
9-HODE	3.193	3.401	0.66	0.57	0.37	0.46	0.76
9,10-EODE	0.499	0.442	0.46	0.85	0.34	0.51	0.74
12,13-EODE	0.559	0.520	0.62	0.94	0.42	0.65	0.57
5-OxoETE	0.016	0.019	0.55	0.22	0.99	0.85	0.15
AA	69.094	67.976	0.72	0.62	0.85	0.71	0.49
LA	19.025	19.528	0.55	0.48	0.22	0.35	0.57

Bold, significantly changed oxylipin (% change > 50%, p < 0.05).